Precision sniper for solid tumors: CAR-NK cell therapy
Abstract Chimeric antigen receptor (CAR) represents a novel targeted therapy that uses genetic engineering to modify effector cells for precise tumor cell targeting. Chimeric antigen receptor-T (CAR-T) cell immunotherapy, which employs T cells as effectors, has demonstrated significant efficacy in t...
Saved in:
| Main Authors: | Sisi Li, Jiajie Jing, Yueming Chen, Enjie Chi, Bingyan Wang, Ziwen Xie, Wenya Yang, Hongqiang Shen, Jianping Pan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Cancer Immunology, Immunotherapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s00262-025-04106-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chimeric antigen receptor-natural killer (CAR-NK) cell immunotherapy: A bibliometric analysis from 2004 to 2023
by: Wangshu Li, et al.
Published: (2024-12-01) -
Engineering CD5-targeting CAR-NK cells from peripheral blood for the treatment of CD5-positive hematological malignancies
by: Haolong Lin, et al.
Published: (2025-04-01) -
CAR‐NK, a Splendid Strategy for Cancer, Especially for Gynecologic Tumor
by: Yisen Cao, et al.
Published: (2025-06-01) -
Application and prospects of genetic engineering in CAR-NK cell therapy
by: Caidong Hu, et al.
Published: (2025-05-01) -
Advancements and challenges in CAR-T cell therapy for solid tumors: A comprehensive review of antigen targets, strategies, and future directions
by: Jiajun Zhu, et al.
Published: (2025-08-01)